Credit Suisse’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.67M | Buy |
85,339
+3,544
| +4% | +$153K | ﹤0.01% | 1470 |
|
|
2023
Q4 | $3.77M | Buy |
81,795
+16,209
| +25% | +$747K | ﹤0.01% | 1499 |
|
|
2023
Q3 | $2.24M | Sell |
65,586
-241
| -0.4% | -$8.23K | ﹤0.01% | 1750 |
|
|
2023
Q2 | $2.53M | Buy |
65,827
+7,757
| +13% | +$299K | ﹤0.01% | 1742 |
|
|
2023
Q1 | $2.08M | Buy |
58,070
+3,281
| +6% | +$117K | ﹤0.01% | 1829 |
|
|
2022
Q4 | $2.16M | Buy |
54,789
+11,136
| +26% | +$439K | ﹤0.01% | 1810 |
|
|
2022
Q3 | $1.58M | Buy |
43,653
+10,469
| +32% | +$378K | ﹤0.01% | 1996 |
|
|
2022
Q2 | $1.01M | Buy |
33,184
+3,034
| +10% | +$92.3K | ﹤0.01% | 2357 |
|
|
2022
Q1 | $922K | Buy |
30,150
+5,246
| +21% | +$160K | ﹤0.01% | 2577 |
|
|
2021
Q4 | $777K | Buy |
24,904
+6,206
| +33% | +$194K | ﹤0.01% | 2749 |
|
|
2021
Q3 | $286K | Buy |
18,698
+81
| +0.4% | +$1.24K | ﹤0.01% | 3269 |
|
|
2021
Q2 | $346K | Sell |
18,617
-5,474
| -23% | -$102K | ﹤0.01% | 3212 |
|
|
2021
Q1 | $432K | Buy |
24,091
+5,613
| +30% | +$101K | ﹤0.01% | 3025 |
|
|
2020
Q4 | $283K | Buy |
18,478
+4,793
| +35% | +$73.4K | ﹤0.01% | 3159 |
|
|
2020
Q3 | $151K | Hold |
13,685
| – | – | ﹤0.01% | 3141 |
|
|
2020
Q2 | $172K | Buy |
+13,685
| New | +$172K | ﹤0.01% | 3129 |
|
|
2019
Q3 | – | Sell |
-14,512
| Closed | -$143K | – | 3501 |
|
|
2019
Q2 | $143K | Buy |
+14,512
| New | +$143K | ﹤0.01% | 3260 |
|